Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Ripple's Schwartz Underestimates XRP Lending Potential, Flare CEO Claims

Ripple's Schwartz Underestimates XRP Lending Potential, Flare CEO Claims

UTodayUToday2026/10/08 07:03

Ripple CTO David Schwartz is underestimating the true potential of lending on the XRP Ledger, and the Flare Networks ecosystem is ready to prove it in practice.

In his view, one of XRP's chief architects is overlooking what many users have also missed - the scale of external infrastructure that can be integrated into Ripple's network.

Philion explains that while the XRPL's native lending protocol, XLS-66, is stalled at the validator voting stage, his team has already built a workaround. Flare is betting that, with Protocol Managed Wallets and its Flare Confidential Compute stack, any application can be built with whatever logic you want.

In Philion's view, these two components will come as close as possible to giving the XRPL full smart contract capabilities.

As a result, any add-on will function as if it were native to the XRPL. Asset holders will be able to lend coins directly from their native wallets, completely avoiding the risks of cross-chain bridges. But the executive's economic incentive is clear: as always, all fees flow into FLARE.

How to put XRP to work right now: Flare's approach

As evidence, Philion points to a lending market that Flare has already deployed on external platforms using FXRP.

While Ripple's native XLS-66 model, designed for off-chain underwriting by Clearpool and Cicada, is still awaiting approval, investors have already borrowed $7.2 million in the new RLUSD stablecoin through Flare's infrastructure, using 10.8 million wrapped XRP as collateral. This highly concentrated sector, where just three addresses currently hold 93% of the debt in Morpho pools and Sentora provides liquidity, despite RLUSD's total supply of $2.4 billion, clearly demonstrates the potential demand.

Summing up his position, Hugo Philion confirmed that his company does have plans for lending on the XRPL.

Rather than wait for major ledger upgrades from Ripple, Flare intends to deploy programmable logic on its own side, thereby channeling new financial flows into its own ecosystem.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals

October 9 – Goldman Sachs pointed out that India's implementation of a 30% profit margin cap on non-scheduled anticancer drugs (link) will have limited impact on hospitals. The report states that, based on preliminary discussions with hospital chain groups, such drugs account for less than 5% of hospital revenue and 2% to 2.5% of operating profit. The report adds that hospitals can offset the losses by slightly adjusting service charges, such as administration fees. According to a government notice, an expert committee will finalize the list of drugs to be brought under regulation. Driven by the anticipated price cap, the share prices of Max Healthcare MAXE.NS, Apollo Hospitals APLH.NS, and Fortis Healthcare FOHE.NS rose by 1.6% to 2.5%. Previously, since September 30, these stocks had collectively declined by 11% to 11.5%. Year-to-date, FOHE and MAXE are down 11.7% and 14.8%, respectively, while APLH has risen by 11%. (To assist non-English speakers, Reuters provides automated translations of its reports into several other languages. Due to potential errors or missing context in automated translations, Reuters does not guarantee the accuracy of automatic translation texts and offers them solely for readers’ convenience. Reuters accepts no responsibility for any damage or loss caused by using these automated translation features.)

路透社•2026/10/09 04:26
BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals